ArticleFrontiers in oncology2026

Case Report: Central nervous system relapse treated with elranatamab after prior BCMA and GPRC5D directed therapies in relapsed/refractory multiple myeloma.

Raúl Pérez-Calle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.